Department of Immunology Mayo Graduate and Medical Schools Mayo Clinic Rochester, Minnesota
chen.lieping@mayo.edu
Tumor cells engineered to overexpress molecules that activate an immune response have shown therapeutic promise in preventing growth of cancers. In a new study, tumor cells studded with a ligand-mimicking antibody fragment beckon their own destruction. (pages 343−348)
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
